These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33296169)

  • 1. Recent Insights into Emerging Coronavirus: SARS-CoV-2.
    Shang Z; Chan SY; Liu WJ; Li P; Huang W
    ACS Infect Dis; 2021 Jun; 7(6):1369-1388. PubMed ID: 33296169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
    JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.
    Zhou H; Ni WJ; Huang W; Wang Z; Cai M; Sun YC
    Front Immunol; 2022; 13():834942. PubMed ID: 35450063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
    Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2.
    Lee SJ; Kim YJ; Ahn DG
    J Microbiol Biotechnol; 2022 Sep; 32(9):1073-1085. PubMed ID: 36039385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19, the firestone in 21st century: a review on coronavirus disease and its clinical perspectives.
    Karthika C; Swathy Krishna R; Rahman MH; Akter R; Kaushik D
    Environ Sci Pollut Res Int; 2021 Dec; 28(46):64951-64966. PubMed ID: 34599450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
    Ahn DG; Shin HJ; Kim MH; Lee S; Kim HS; Myoung J; Kim BT; Kim SJ
    J Microbiol Biotechnol; 2020 Mar; 30(3):313-324. PubMed ID: 32238757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Prospective Challenges and Potential Vaccines.
    Shahid Nadeem M; Ali A; Al-Ghamdi MA; Depfenhart M; Azam Khan J; Zamzami MA; Nazia Murtaza B; Kazmi I; Ur Rehman M
    Altern Ther Health Med; 2020 Aug; 26(S2):72-78. PubMed ID: 32845250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of COVID-19: A Detailed Overview and Its Consequences.
    Shivalkar S; Pingali MS; Verma A; Singh A; Singh V; Paital B; Das D; Varadwaj PK; Samanta SK
    Adv Exp Med Biol; 2021; 1353():23-45. PubMed ID: 35137366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV2 Outbreak: Emergence, transmission and clinical features of human coronaviruses.
    Imran M; Yasmeen R
    J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S710-S713. PubMed ID: 33754539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
    De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
    Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.